<DOC>
	<DOC>NCT02543034</DOC>
	<brief_summary>This study is a randomized, controlled, multi-centre, open-label, phase IV study. Total 81 patients will be enrolled in this study. Patients will be randomly assigned to Betafoam®, petrolatum gauze or Allevyn for donor site wounds after skin graft operation.</brief_summary>
	<brief_title>Study of Petrolatum Gauze, Allevyn, and New Antiseptic Dressing, Betafoam® Dressing, in the Management of Split-Thickness Skin Graft Donor Site</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents, Local</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>1. Patients who is same as or more than 19 years old 2. Patients who will receive elective skin harvest operation 3. Patients who is in lateral thigh or buttock with donor site area from 50 to 150 cm2 4. Female patients who use method of contraception for the study 5. Patients who voluntarily sign the informed consent 1. Patients who are pregnant 2. Patients who are known to have allergy to the dressing product including PVPI 3. Known hyperthyroidism or other thyroid dysfunction such as nodular thyroid goiter, endemic goiter and Hashimoto's thyroiditis or patients who receive radioiodine therapy 4. Comorbidities which may adversely affect wound healing for example a patient with uncontrolled diabetes (HbA1c &gt; 8%), chronic renal failure, autoimmune disease, or immunocompromised patient 5. Patients who receive anticoagulants, steroids or immunosuppressants 6. Patients who have signs and symptoms of infection on enrollment and adversely affect wound healing 7. Patients who have skin lesion such as Herpes zoster on donor site 8. Burn of &gt;20% total body surface area 9. If the donor site had been harvested on a previous occasion 10. Patients who is limited cognitive ability 11. Patients who are participating in or will plan to participate in other clinical trials 12. Other various conditions that the investigators judge inappropriate for enrolment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>